PCPredrag Canovic

Predrag Canovic

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Predrag Canovic has a total of 88 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Cholestatic viral hepatitis a with refractory pruritus successfully treated with a combination of molecular adsorbent recirculating system and corticosteroids: A case report

    by Nemanja Đorđević, Predrag Čanović, Dejan Petrović, Nataša Minić, Željko Mijailović

    Hepatitis A virus is a major cause of acute viral hepatitis worldwide, with approximately 1.5 million cases annually. Clinical manifestations of the hepatitis A virus infection range from asymptomatic to acute liver failure. Cholestatic viral hepatitis A is a rare clinical manifestation characterized by a prolonged course, refractory pruritus, imminent acute liver failure and generally good prognosis. The treatment of pruritus in cholestatic viral hepatitis A can be challenging because a response to conventional therapy is limited. We present the effects of a combination of pulse doses of prednisolone and two cycles of MARS (Molecular Adsorbent Recirculating System) in the treatment of a young female patient with cholestatic viral hepatitis A. This treatment option significantly reduced the duration of the disease and the intensity of pruritus and led to full recovery of the patient and normalization of laboratory parameters of cholestasis. This treatment combination has proven to have significant and lasting effects with no relapse of pruritus. Low doses of corticosteroids administered for a short time reduce the risk of side effects. The importance of vaccination of international travellers should be also pointed out here.


  • Open Access

    Significance of initial clinical laboratory parameters as prognostic factors in patients with COVID 19

    by Biljana Popovska-Jovicic, Ivana Rakovic, Aleksandar Pavkovic, Vladan Markovic, Sara Petrovic, Jagoda Gavrilovic, Predrag Canovic, Ruzica Radojevic-Marjanovic, Marko Folic

    Background/Aim. COVID 19 is a predominantly respiratory disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The aim of this study was to determine whether there are significant variables which could predict severe clinical picture and fatal outcome in COVID 19 patients. Methods. The research involved 632 patients who were treated at the University Medical Center Kragujevac at the Clinic for Infectious Diseases, in the period from June 2020 to February 2021. All patients were divided into two groups according to the need for oxygen therapy (Sat 02 < 94. Results. Our results showed that high BMI was singled out as a risk factor for the development of a severe clinical picture [BMI [ORadjusted = 1.263; 95% CI = 1.117 - 1.427; p < 0.001]]. Prothrombin time (ORadjusted = 1.170; 95% CI = 1.004 - 1.364; p = 0.045), as well as low albumin values (ORadjusted = 0.878; 95% CI = 0.804 - 0.958; p = 0,003) had a predictive significance for the development of severe clinical picture. Factors that were of predictive importance in patients with fatal outcome were CRP (ORadjusted = 1.010; 95% CI = 1.001 - 1.019; p = 0.031), LDH (ORadjusted = 1.004; 95% CI = 1.001 - 1.006; p = 0.002). X-ray of the lungs (ORadjusted = 1.394; 95% CI = 1.170 - 1.661; p < 0.001). Conclusion. Research has shown that routine, clinical-laboratory parameters can be important in the early detection of patients with a potentially severe clinical picture and fatal outcome. In patients with a mild clinical picture, CRP, LDH, ferritin, and serum albumin levels may indicate timely disease progression. Monitoring of parameters of essential importance for the timely clinical assessment of patients with COVID 19, and thus the timely application of adequate therapeutic protocols in the treatment of these patients.


  • Synthesis, Characterization and Biological Studies of Organoselenium trans-Palladium(II) Complexes

    by Ivana Raković, Jovana Bogojeski, Katarina Mladenović, Angelina Petrović, Vera Divac, Kristina Mihailović, Biljana Popovska Jovicić, Marina Kostić, Predrag Canović, Nevena Milivojević, et al.

    Background: Over the years, transition metal complexes have exhibited significant antimicrobial and antitumor activity. It all started with cisplatin discovery, but due to the large number of side effects it shows, there is a growing need to find a new metal-based compound with higher selectivity and activity on more tumors. Objectives: Two novel trans-palladium(II) complexes with organoselenium compounds as ligands, [Pd(L1)2Cl2] (L1 = 5-(phenylselanylmethyl)-dihydrofuran-2(3H)-one) and [Pd(L2)2Cl2] (L2 = 2- methyl-5-(phenylselanylmethyl)- tetrahydrofuran) were synthesized, in the text referred to as Pd-Se1 and Pd-Se2. Also, a structurally similar trans-palladium(II) complex, [Pd(L3)2Cl2] (L3= 2,2- dimethyl-3-(phenylselanylmethyl)-tetrahydro-2H-pyran) was synthesized according to an already published work and is referred to as Pd-Se3. The interaction of synthesized complexes with DNA and bovine serum albumin was observed. Also, antimicrobial activity and in vitro testing, cell viability, and cytotoxic effects of synthesized ligands and complexes on human epithelial colorectal cancer cell line HCT-116 were studied. Molecular docking simulations were performed to understand better the binding modes of the complexes reported in this paper with DNA and BSA, as well as to comprehend their antimicrobial activity. Methods: The interactions of the synthesized complexes with DNA and bovine serum albumin were done using UV-Vis and emission spectral studies as well as docking studies. Antimicrobial activity was tested by determining the minimum inhibitory concentrations (MIC) and minimum microbicidal concentration (MMC) using the resazurin microdilution plate method. Cytotoxic activity on cancer cells was studied by MTT test. Results: The Pd(II) complexes showed a significant binding affinity for calf thymus DNA and bovine serum albumin by UV-Vis and emission spectral studies. The intensity of antimicrobial activity varied with the complexes Pd-Se1 and Pd-Se3, showing significantly higher activity than the corresponding ligand. The most significant activity was shown on Pseudomonas aeruginosa. Under standardized laboratory conditions for in vitro testing, cell viability and cytotoxic effects of synthesized ligands and complexes were studied on human epithelial colorectal cancer cell line HCT-116, where Pd-Se2 showed some significant cytotoxic effects. Conclusion: The newly synthesized complexes have the potential to be further investigated as metallodrugs.


  • Open Access

    Local guidelines for drug treatment of patients with COVID-19

    by Slobodan Janković, Katarina Pavlović, Vladimir Vukićević, Jagoda Gavrilović, Marko Folić, Predrag Čanović, Ružica Marjanović, Slavica Mojsilović, Nebojša Stevanović, Nikola Rosić

    Objective. Until now, there have been no guidelines for the use of drugs in patients with COVID 19 in the Republic of Serbia that have been authorized and published in the professional or scientific literature, or on the official websites of the Ministry of Health or healthcare institutions. The aim of this paper is to present a local guideline for the use of drugs in patients with COVID 19 and the process of its development and adoption. Methods. The guideline proposal was prepared by a working group based on the results of a systematic research of the medical literature, and quality control of found publications from the category "clinical practice guidelines". The proposal of the working group was considered and adopted at the sessions of the Drug / Therapeutics Committee and the Quality Assurance Committee of the University Clinical Centre Kragujevac. Results. The guideline's recommendations are based on the type of patient, and all have the same degree of recommendation and the same quality of evidence on which they are based. Patient types are formed according to the severity of the disease and the need for respiratory support, as well as according to the risk of secondary bacterial infection. Conclusion. The local guideline to the use of drugs in patients with COVID 19 was developed and adopted in a short period of time, primarily due to the need for its urgent use. A revision of this guide is planned after 6 months from the moment of adoption.


  • Open Access

    Malaria in the 21st century - still a threatening problem

    by Predrag Canovic, Biljana Popovska-Jovicic, Milorad Pavlovic

    There are six parasite species (P. falciparum, P. vivax, P. ovale curtisi, P. ovale wallikeri, P. malariae, and P. knowlesi) that cause malaria in humans. P. falciparum is responsible for most malaria-related deaths globally. P. vivax is the dominant malaria parasite in most countries outside of the Sub-Saharan Africa. In 2016, 91 countries reported a total of 216 million cases of malaria. The global tally of malaria deaths reached 445,000. In 2016, 24 cases of imported malaria were registered in the Republic of Serbia, with an incidence of 0.33/100,000. According to the World Health Organization recommendations, every suspected malaria case should be confirmed by microscopy or a rapid diagnostic test before treatment. The main stone of antimalarial therapy should be artemisinin-based combinations. Since malaria occurs in Europe as an imported (though rarely also autochthonous and a hospital-borne infection), the objective of this paper is to point out current problems and attitudes in the diagnosis and treatment of malaria, without entering the data field significant for professionals (infectologists, epidemiologists, intensivists).

  • Open Access

    Antimicrobial, antioxidant and DNA-binding studies of palladium(II) complexes with different chelate ligands containing nitrogen donor atoms

    by Ivana R. Raković, Ivana D. Radojević, Katarina G. Mladenović, Biljana D. Popovska-Jovičić, Sara Petrovic, Petar P. Čanović, Ljiljana R. Čomić, Predrag S. Čanović, Jovana V. Bogojeski

    The antimicrobial and antioxidant activities, as well as the DNA-binding of four square-planar Pd(II) complexes, [Pd(terpy)Cl]+ (C1), [Pd(en)Cl2] (C2), [Pd(DMEAImiPr)Cl2] (C3) and [Pd(dach)Cl2] (C4) (terpy = 2,2?:6?,2??- -terpyridine, en = ethylenediamine, dach = trans-1,2-diaminocyclohexane and DMEAImiPr = N2-((1,3-dihydro-1,3-diisopropyl-4,5-dimethyl)-2H-imidazol-2- ylidene)-N1,N1-dimethyl-1,2-ethanediamine are reported. The antimicrobial activities of the Pd(II) complexes with the appropriate ligands were tested using the microdilution method against 18 strains of microorganisms, whereby the minimal inhibitory concentration (MIC) and the minimal microbicidal concentration (MMC) were determined. The antibiofilm activity of [Pd(terpy)Cl]+ and the corresponding ligand were determined on a formed biofilm. The intensity of antimicrobial activity varied depending on the type of microorganism and the tested compound. The C1 complex with the corresponding ligand demonstrated significantly greater overall antimicrobial activity than C2, C3 and C4. The antibacterial activity of the C1 complex was better than its antifungal activity that was overall greater than that of the positive control, fluconazole. The greatest sensitivity for C1 and L1 was with Penicillium italicum (MIC < 0.49 ?g mL-1) among the fungi, and with Proteus mirabilis ATCC 12453 (MIC = 0.98 ?g mL-1) among the tested bacteria. The tested compounds show low and moderate antibiofilm activity. The complexes showed weak antioxidant properties when tested using the DPPH (1,1-diphenyl-2- -picrylhydrazyl) method. The interaction of the metal complexes C1?C4 with calf thymus DNA (CT-DNA) was further examined by absorption (UV?Vis) and emission spectral studies (EthBr displacement studies). Overall, the investigated complexes exhibited good DNA interaction ability.


  • The outcome of Pneumocystis jiroveci pneumonia complicated with ventilator - associated pneumonia in a patient suffering from acquired immunodeficiency syndrome: A case report

    by Sara Petrovic, Popovska Jovicic, Ivana Rakovic, Predrag Canovic, Ljiljana Nesic, Ivica Petrovic

    Introduction. The respiratory tract is the most common site of opportunistic infections in patients with acquired immunodeficiency syndrome, and respiratory failure is the leading cause of death in these cases. In addition, the use of mechanical ventilation in the treatment of respiratory failure carries a high risk of nosocomial pneumonia caused by multidrug-resistant strains of bacteria. Case report. We present a human immunodeficiency virus-positive patient with positive outcome of Pneumocystis jiroveci pneumonia whose condition progressed to acute respiratory distress syndrome with the development of complications associated with mechanical ventilation. As soon as an opportunistic infection was suspected, trimethoprim-sulfamethoxazole and corticosteroid therapy were initiated, with a short application of mechanical ventilation. Despite a good initial response to treatment, during the mechanical ventilation, a relapse of fever occurred, as well as development of productive cough, new zones of consolidation on chest X-ray and Acinetobacter spp. was isolated in a swab culture. According to the literature recommendations, colistinmeropenem combination was conducted with adequate response. The patient was discharged after 22 days of treatment, in good general condition, afebrile, with normal laboratory parameters and gas exchange, without subjective symptoms. Conclusion. Early identification of Pneumocystis jiroveci pneumonia, timely initiation of prophylaxis and treatment, along with antiretroviral therapy, re?duced the risk of severe clinical events and respiratory failure. Also, timely recognition of complications of mechanical ventilation, identification of infection, early extubation and application of appropriate antibiotic therapy, reduce the mortality from nosocomial pneumonia caused by multi-drug resistant hospital strains of microorganisms.


  • Open Access

    Fever of unknown origin: Most frequent causes in adults patients

    by Biljana Popovska-Jovicic, Predrag Canovic, Olgica Gajovic, Ivana Rakovic, Zeljko Mijailovic

    Background/Aim. The differential diagnosis of fever of unknown origin (FUO) includes more than 200 different diseases and conditions. The aim of this study was to identify the most frequent causes of FUO among adult patients according to gender and age. Methods. The study included 74 patients examined from June 2010 to June 2013 at the Infectious Disease Clinic, Clinical Center Kragujevac in Serbia, according to the defined criteria for FUO. The patients were divided according to the diagnosis into four groups: infectious, malignant, rheumatic and "other diseases". A cause of febricity could not be estabilshed in a portion of subjects, and they comprised the group of undiagnosed cases. Results. Infectious diseases were dominant in the study, followed by rheumatic diseases, which were most frequently found in women and the elderly. The diseases recognised as the most common causes of febricity were subacute thyroiditis, subacute endocarditis, Still?s disease, rheumatic polymyalgia with or without temporal arteritis, and cytomegalovirus infection. In 44% of the patients, the final diagnosis was composed of only six clinical entities. Conclusion. The importance of establishing the diagnosis of rheumatic disease is especially emphasised, in line with other authors? research indicating the number of these diseases is on the rise. The diagnostic approach to FUO should always be directed to the known frequency of diseases.


  • Open Access

    Lack Of PRSS1 And SPINK1 Polymorphisms In Serbian Acute Pancreatitis Patients

    by Ivan Radosavljevic, Andjela Milojevic, Jelena Miljkovic, Ana Divjak, Ivana Jelic, Viktorija Artinovic, Marko Spasic, Bojan Stojanovic, Predrag Canovic, Slobodan Jankovic, et al.

    Acute pancreatitis represents an acute nonbacterial inflammation of the pancreas caused by a premature and ectopic activation of pancreatic digestive enzymes. Two of the most important genes in pancreatic autodigestion, PRSS1 and SPINK1, were implicated in the earliest discoveries of the genetic background of pancreatitis. However, the distribution of their variations displays interethnic variability, which could significantly affect the magnitude of their proposed effects on this disease worldwide. The aim of the present study was to investigate the distribution of the most important functional variations of PRSS1 (86A>T and 365G>A) and SPINK1 (101A>G), and their influence on the clinical course of acute pancreatitis in Serbian patients. The study enrolled 81 subjects, the severity of disease course was determined using the Atlanta Classification system, and the genotyping was conducted using a PCR-RFLP method. PRSS1 86A>T and 365G>A SNPs were not observed in the study population, while SPINK1 101A>G was present with the frequency of 0.62% (95% CI: 0.00, 3.83%). Due to extremely low frequencies or absences of examined variations, the proposed effect of these SNPs on the severity of acute pancreatitis could not be confirmed. The results do not support routine genotyping of either PRSS1 or SPINK1 in Serbs.

  • Open Access

    Assessment of Viral Genotype Impact to the Cost-Effectiveness and Overall Costs of Care for Peg-Interferon-2α + Ribavirine Treated Chronic Hepatitis C Patients

    by Jakovljevic B. Mihajlo, Miјailovic D. Zeljko, Popovska Jovicic D. Biljana, Canovic S. Predrag, Gajovic M. Olgica, Jovanovic R. Mirjana, Petrovic S. Dejan, Milovanovic Z. Olivera, Djordjevic D. Natasa

    Background: Pegylated interferon alfa plus ribavirin protocol is currently considered the most efficient hepatitis C treatment. However, no evidence of costs comparison among common viral genotypes has been published. Objectives: We aimed to assess core drivers of hepatitis C medical care costs and compare cost effectiveness of this treatment among patients infected by hepatitis C virus with genotypes 1 or 4 (group I), and 2 or 3 (group II). Patients and Materials: Prospective bottom-up cost-effectiveness analysis from societal perspective was conducted at Infectious Diseases Clinic, University Clinic Kragujevac, Serbia, from 2007 to 2010. There were 81 participants with hepatitis C infection, treated with peg alpha-2a interferon plus ribavirin for 48 or 24 weeks. Economic data acquired were direct inpatient medical costs, outpatient drug acquisition costs, and indirect costs calculated through human capital approach. Results: Total costs were significantly higher (P = 0.035) in group I (mean ± SD: 12,751.54 ± 5,588.06) compared to group II (mean ± SD: 10,580.57 ± 3,973.02). In addition, both direct (P = 0.039) and indirect (P < 0.001) costs separately were significantly higher in group I compared to group II. Separate comparison within direct costs revealed higher total cost of medical care (P = 0.024) in first compared to second genotype group, while the similar tendency was observed for total drug acquisition (P = 0.072). Conclusion: HCV genotypes 1 and 4 cause more severe clinical course require more care and thus incur higher expenses compared to HCV 2 and 3 genotypes. Policy makers should consider willingness to pay threshold differentially depending upon HCV viral genotype detected. Keywords: Cost-Benefit Analysis; Interferons; Ribavirin; Hepatitis C, Chronic